ServiziMenu principaleHome
Home > Past events > ABC3 > Faculty and Panel Members
Share on Share on Facebook Twitter Share on Linkedin Print this page

ABC3 Faculty and Panel Members

 ABC3 Chairs

Fatima Cardoso Alberto Costa
Larry Norton
Eric Winer
Fatima Cardoso
Breast Cancer Unit
Champalimaud Cancer Center
Lisbon, PT
Alberto Costa
Scientific Director
European School of Oncology
Milan IT and Bellinzona, CH
Larry Norton
Breast Cancer Programs
Memorial Sloan-Kettering Cancer Centre
New York, US
Eric P. Winer
Breast Oncology Center
Dana-Farber Cancer Institute
Boston, US

Faculty Members

Matti S. Aapro
IMO Clinique De Genolier, Institut Multidisciplinaire d'Oncologie, Genolier, CH

Fabrice André
Department of Medical Oncology,Gustave Roussy Institute, Villejuif, FR

Sam Aparicio
Department of Breast and Molecular Oncology, University of British Columbia and the BC Cancer Agency, Vancouver, CA

Carlos H. Barrios
Department of Medicine, PUCRS School of Medicine, Porto Allegre, BR

Marc Beishon
Cancer World, London, UK

Jonas Bergh
Department of Oncology-Pathology, Karolinska Institute, Stockholm, SE

Gouri S. Bhattacharyya
Department of Medical Oncology, Fortis Hospital, Kolkata, IN

Laura Biganzoli
Department of Medical Oncology, Sandro Pitigliani Oncology Centre, Prato, IT

Maria João Cardoso
Breast Unit, Champalimaud Cancer Center and MamaHelp, Lisbon, PT

Lisa A. Carey
Department of Hematology and Oncology, UNC Lineberger Comprehensive Cancer Center, North Carolina, US

Sarbani Chaudhuri
Pfizer Oncology, New York, US

Robert E. Coleman
Academic Unit of Clinical Oncology, University of Sheffield & Weston Park Hospital, Sheffield, UK

Dian “CJ” M. Corneliussen-James
METAvivor Research and Support, Annapolis, US

Giuseppe Curigliano
Division of Experimental Therapeutics, European Institute of Oncology, Milan, IT

Véronique Dieras
Department of Medical Oncology, Institut Curie, Paris, FR

Nagi S. El Saghir
NK Basile Cancer Institute, American University of Beirut Medical Center, Beirut, LB

Alexander Eniu
Department of Breast Tumors, Cancer Institute "I. Chiricuta", Cluj-Napoca, RO

Lesley Fallowfield
Sussex Health Outcomes Research & Education in Cancer, Brighton & Sussex Medical School, University of Sussex, Brighton, UK

Doris Fenech
Breast Care Support Group, Europa Donna Malta, Mtarfa, MT

Patrick Flamen
Department of Nuclear Medicine, Jules Bordet Institute, Brussels, BE

Prudence A. Francis
Division of Cancer Medicine, Peter MacCallum Cancer Centre, Melbourne, AU

Karen Gelmon
Department of Medical Oncology, BC Cancer Agency, Vancouver, CA 

Alessandra Gennari
Department of Medical Oncology, Galliera Hospital, Genoa, IT

Nadia Harbeck
Breast Center, University of Munich, Munich, DE

Jens Hoffmann
EPO Experimental Pharmacology & Oncology Berlin-Buch GmbH, Berlin, DE

Clifford A. Hudis
Breast Medicine Service, Memorial Sloan-Kettering Cancer Centre, New York, US

Bella Kaufman
Department of Oncology, Sheba Medical Center, Tel Hashomer, IL

Ian E. Krop
Breast Oncology Center, Dana-Farber Cancer Institute, Boston, US

Musa Mayer
AdvancedBC.org, New York, US

Hanneke Meijer
Department of Radiation Oncology, Radboud University Medical Center, Nijmegen, NL

Shirley A. Mertz
Metastatic Breast Cancer Network US, Inverness, US

Shinji Ohno
Breast Oncology Centre, Cancer Institute Hospital, Tokyo, JP

Olivia Pagani
Breast Unit, Oncology Institute of Southern Switzerland, Bellinzona, CH

Evi Papadopoulos
Europa Donna, Nicosia, CY

Fedro A. Peccatori
Deputy Scientific Director, European School of Oncology, Milan, IT and Bellinzona, CH

Frédérique Penault-Llorca
Department of Pathology, Jean Perrin Centre, Comprehensive Cancer Centre, Clermont Ferrand, FR

Martine J. Piccart
Department of Medicine, Jules Bordet Institute, Brussels, BE

Jean-Yves Pierga
Department of Medical Oncology, Institut Curie, Paris Cancer Center, Paris, FR

Fausto Roila
Department of Medical Oncology, Monteluce Policlinic, Perugia, IT

Hope S. Rugo
Breast Oncology and Clinical Trials Education, UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, US 

Kimberly A. Sabelko
Susan G. Komen, Dallas, US

Elzbieta Senkus-Konefka
Department of Oncology and Radiotherapy, Medical University of Gdansk, Gdansk, PL

Lillie D. Shockney
Depts of Surgery and Oncology, Johns Hopkins Breast Center, Baltimore, US

George W. Sledge
Division of Oncology, Stanford School of Medicine, Stanford, US

Danielle Spence
Breast Cancer Network Australia, Camberwell, AU

Sandra M. Swain
Washington Cancer Institute, MedStar Washington Hospital Center, Washington DC, US

David G. Taylor
School of Pharmacy, University College London, London, UK

Christoph Thomssen
Clinic for Gynaecology, Martin-Luther-Universität, Klinikum Kröllwitz, Halle (Saale), DE

Luzia Travado
Department of  Psycho-Oncology, Champalimaud Clinical Centre, Lisbon, PT

Andrew Tutt
Breakthrough Breast Cancer Research Unit, King’s College London and Guy’s and St Thomas’ NHS Foundation Trust, London, UK

Daniel A. Vorobiof
Sandton Oncology Centre, Johannesburg, ZA

Binghe Xu
Department of Medical Oncology, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, CN

Consensus Panellists

Matti S. Aapro, CH
Fabrice André, FR
Carlos H. Barrios, BR
Jonas Bergh, SE
Gouri S. Bhattacharyya, IN
Laura Biganzoli, IT
Fatima Cardoso, PT
Maria João Cardoso, PT
Dian ”CJ”  Corneliussen-James, US
Alberto Costa, IT
Giuseppe Curigliano, IT
Véronique Dieras, FR
Nagi S. El Saghir, LB
Alexander Eniu, RO
Lesley Fallowfield, UK
Doris Fenech, MT
Patrick Flamen, BE
Prudence A. Francis, AU
Karen Gelmon, CA
Alessandra Gennari, IT
Nadia Harbeck, DE
Clifford A. Hudis, US
Bella Kaufman, IL
Ian E. Krop, US
Musa Mayer
, US
Hanneke Meijer, NL
Shirley A. Mertz, US
Larry Norton, US
Shinji Ohno, JP
Olivia Pagani, CH
Evi Papadopoulos
, CY
Fedro A. Peccatori, IT/CH
Frédérique Penault-Llorca
, FR
Martine J. Piccart, BE
Jean-Yves Pierga, IT
Hope S. Rugo
, US 
Elzbieta Senkus-Konefka, PL
Lillie D. Shockney, US
George W. Sledge, US
Sandra M. Swain, US
Christoph Thomssen, DE
Andrew Tutt, UK
Daniel A. Vorobiof, ZA
Eric P. Winer, US
Binghe Xu, CN

Breast cancer Patient Advocacy Committee


Fatima Cardoso, Breast Unit, Champalimaud Cancer Center, Lisbon, PT
Marc Beishon, Cancer World, London, UK
Maria João Cardoso, MamaHelp, Lisbon, PT
Dian “CJ” M. Corneliussen-James, METAvivor Research and Support, Annapolis, US
Musa Mayer, AdvancedBC.org, New York, US
Shirley A. Mertz, Metastatic Breast Cancer Network US, Inverness, US
Evi Papadopoulos, Europa Donna, Nicosia, CY
Danielle Spence, Breast Cancer Network Australia, Camberwell, AU
Kimberly A. Sabelko, Komen Foundation, Dallas, US

Disclosure of Conflict Interest

Faculty members have been asked to disclose any potential conflict of interest in relation to their participation in the Conference.  Potential conflict of interest are considered any of the following:
Any financial interest in or arrangement with a company whose products or services are discussed in the lecture or that might be considered as part of the consensus process.
Any financial interest in or arrangement with a competing company.
Any other financial relationship, direct or indirect, or other situations that might raise the question of bias in the work presented or in the participation in the consensus process, including pertinent commercial or other sources of funding for the speaker or panellist or for the associated department or organisation, personal relationships or direct academic competition.

Matti Aapro: Consultant for Abraxis, Amgen, BMS, CarisLifeSciences, Celgene, Eisai, GenomicHealth, GSK, Helsinn, Hospira, Novartis, Merck, Merck Serono, Pfizer, Pierre Fabre, Roche, Sandoz, Teva, Vifor and has received honoraria for lectures at symposia f Amgen, Astellas, Bayer Schering, Cephalon, Eisai, Ferring, Genomic Health, GSK, Helsinn, Hospira, Ispen,  JnJ OrthoBiotech, Merck, Merck Serono, Novartis, Pfizer, Pierre Fabre, Roche, Sandoz, Sanofi, Teva, Vifor.
Fabrice Andre: No significant relationships.
Samuel Aparicio: Receipt of grants/research supports: Takeda Biopharma.
Carlos H. Barrios: Receipt of grants/research supports: Amgen, Astra Zeneca, Boehringer-Ingelheim, GSK, Novrtis, Pfizer, Roche/Genentech, Eisai, Lilly, Sanofi-Aventis, Celgene and has received honoraria or consultation fees from:  Boehringer-Ingelheim, GSK, Novartis, Pfizer, Roche/Genentech.
Marc Beishon: Receipt of honorarium: Pfizer.
Jonas Bergh: Receipt of grants/research supports paid to Karolinska Institute and University Hospital: Roche, Bayer, Sanofi-Aventis, Astra Zeneca, Pfizer, Merck, Amgen.
Gouri Shankar Bhattacharyya: No significant relationships.
Laura Biganzoli: No significant relationships.
Fatima Cardoso: Receipt of honoraria or consultation fees:  Astellas/medication, Astra Zeneca, Celgene, Daiichi-Sankyo, Eisai, GE Oncology, Genentech, GSK, Merck-Sharp, Merus BV, Novartis, Pfizer, Roche, Sanofi.
Maria-João Cardoso: No significant relationships.
Lisa A. Carey: No significant relationships.
Sarbani Chaudhuri: Full time employee of Pfizer.
Dian “CJ” M. Corneliussen-James: Receipt of honoraria for work for ABC3.
Alberto Costa: No significant relationships.
Robert E. Coleman: Receipt of grants/research supports: Bayer, Celgene. Expert testimony: Novartis.
Giuseppe Curigliano: No significant relationships.
Véronique Dieras: Receipt of honoraria or consultation fees:  Roche, Genentech, Novartis, Eisai. Participation in a sponsored speakers bureau:  Roche, Pfizer.
Nagi S. El Saghir: Receipt of grants/research supports:  GSK, Novartis, Roche. Receipt of honoraria or consultation fees:  lecture honoraria: Novartis, Roche, MSD, AstraZeneca, Celgene.
Alexandru Eniu: Receipt of grants/research supports:  Astra Zeneca, Roche, Celltrion, Pfizer, Mylan.
Lesley Fallowfield: No significant relationships.
Doris Fenech: No significant relationships.
Patrick Flamen: Receipt of grants/research supports: Sirtex/Bayer, receipt of honoraria or consultation fees:  Sirtex/Bayer.
Prudence A. Francis: Conference travel support from Roche and Amgen.
Karen Gelmon: Receipt of honoraria or consultation fees: Roche, Genetech, Astra Zeneca, Pfizer, Nanostring, Novartis.
Alessandra Gennari: Receipt of grants/research supports: Celgene/Teva, receipt of honoraria or consultation fees:  Celgene, Teva, Eisai, Pierre Fabre, participation in a sponsored speakers bureau:  Celgene, Teva, Eisai.
Nadia Harbeck: Receipt of honoraria or consultation fees:  Amgen, Astra Zeneca, Celgene, Novartis, Pfizer, Roche.
Jens Hoffmann: Employee or stock shareholder: EPO-Experimental Oncology and Pharmacology Berlin-Buch GmbH, Bayer Pharma AG.
Clifford Hudis: No significant relationships.
Bella Kaufman: Receipt of honoraria:  AstraZeneca, Novartis, Pfizer and Roche.
Ian E. Krop: Receipt of grants/research supports:  Genentech/Roche.
Musa Mayer: No significant relationships.
Hanneke Meijer: No significant relationships.
Shirley A. Mertz: Receipt of honoraria or consultation fees: Pfizer.
Larry Norton: No significant relationships.
Shinji Ohno: No significant relationships.
Olivia Pagani: Participation in a sponsored speakers bureau:  Novartis, Celgene.
Evi Papadopoulos: No significant relationships.
Fedro A. Peccatori: No significant relationships.
Frédérique Penault-Llorca: No significant relationships.
Martine J. Piccart: Board member: PharmaMar; consultant (honoraria:  Amgen, Astellas, AstraZeneca, Bayer, Eli Lilly, Invivis, MSD, Novartis, Pfizer, Roche-Genentech, Sanofi Aventis, Symphogen, Synthon, Verastem; research grants to my institute  most companies.
Jean-Yves Pierga: Receipt of grants/research supports:  Roche, Jansen Diagnostics; receipt of honoraria or consultation fees:  Roche, GSK, Novrtis, Genomic Health; participation in a sponsored speakers bureau:  Roche, Novartis.
Fausto Roila: No significant relationships.
Hope S. Rugo: Receipt of grants/research supports: GSK, Genentech/Roche, Novartis, Merck, Pfizer, Eisai, Macrogenics, Amgen, Biomarin, Plexxikon.
Kimberly A. Sabelko: No significant relationships.
Elzbieta Senkus-Konefka: Receipt of honoraria or consultation fees:  Astellas, Janssen, Bayer, Roche, AstraZeneca, GSK, Amgen, Pierre Fabre, Teva; travel expenses:  Roche, Novartis, Janssen, Astellas, Amgen, Sandoz, Ipsen, Bayer, Egis.
Lille D. Shockney: No significant relationships.
George W. Sledge Jr.: Member Board of Directors:  Syndax; member SAB: Symphogen.
Danielle Spence: No significant relationships.
Sandra Swain: Receipt of grants/research supports:  Genentech/Roche, Pfizer, Puma; receipt of honoraria or consultation fees:  Genentech/Roche, Clinigen, Astra Zeneca; participation in a sponsored speakers bureau; nonpromotional Genentech/Roche; spouse/partner:  travel:  Genentech/Roche; travel: Genentech/Roche.
David G. Taylor: Receipt of grants/research supports:  Novartis; receipt of honoraria or consultation fees: Novartis.
Christoph Thomssen: No significant relationships.
Luzia Travado: Receipt of honoraria or consultation fees:  Roche, Novartis.
Andrew Tutt: Receipt of grants/research supports:  Vertex, Astra Zeneca, Myriad Genetics, Roche; receipt of honoraria or consultation fees:  Verte, Eisai; named on patent (King’s College London) Genome Instability; rewards to Inventors Scheme- Institute of Cancer Research ARP inhibitors BRCA1/2 Associated Cancers.
Daniel A. Vorobiof: No significant relationships.
Eric Winer: Receipt of grants/research supports:  Genentech/Roche.
Binghe Xu: No significant relationships.

VAT/NIPC 515 732 230